Who invested in Exsilio Therapeutics?
Exsilio Therapeutics's investors include Insight Partners, OrbiMed, JP Morgan, Innovation Endeavors and Invus.
Who invested in Exsilio Therapeutics
Funding summaryUpdated 26 Oct 2026
$82Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $82MJun 2024
- Investors
- 5
The rounds
- Jun 2024Series A$82M
Source recordedSEC filing: $39M sold, first sale Apr 2024
Founders and team
From Exsilio Therapeutics's own website: 14 on the team.
- Jake OlinVice President & Head Of Business Development
- Tom BarnesCEO & Board Member
- Christian DombrowskiCTO
- Richard MorrisCFO
- Pazit Enker OhanaGeneral Manager & Head Of Global Operations
- Summer BustoHead Of HR
- Dylan MorrisBoard Member
- Henry ChenBoard Member
- Laura BrassBoard Member
- Nick OlsenBoard Member
- Raju PrasadBoard Member
- Roy AmariglioBoard Member
- Steven SquintoBoard Member
- Tal ZaksExecutive Chairman Of The Board
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Exsilio Therapeutics
How much has Exsilio Therapeutics raised?
Exsilio Therapeutics has raised $82M across 1 round since 2024.
When did Exsilio Therapeutics last raise?
Exsilio Therapeutics's most recent round was a Series A of $82M in Jun 2024.
What was Exsilio Therapeutics's biggest round?
Its most recent round, $82M in Jun 2024, is also its largest on record.
Who backed Exsilio Therapeutics first?
Exsilio Therapeutics's first round on record, in Jun 2024, was backed by Insight Partners, OrbiMed and JP Morgan and 2 others.
What stage is Exsilio Therapeutics at?
Exsilio Therapeutics's latest named round is a Series A, in Jun 2024.
Companies like Exsilio Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.